We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AIBG:LSEAIB Group plc Analysis

Data as of 2026-05-27 - not real-time

£876.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Technical momentum is firmly bullish, with price trading above the 20‑day and 50‑day SMAs and the MACD line comfortably above its signal, while the RSI sits in the upper‑mid range, indicating continued upside potential. Increasing volume supports the price advance, and recent regulatory disclosures highlight a ~5% rise in customer loans and modest deposit growth, reinforcing earnings momentum. The stock also offers an exceptionally high dividend yield of over 9%, backed by a robust cash pile exceeding €47 bn and a modest payout ratio, suggesting dividend sustainability. However, volatility over the past month is elevated, and the beta of roughly 0.58 points to lower systematic risk relative to the market.
From a valuation perspective, the discounted cash‑flow model estimates a fair value near double the current market level, implying a deep undervaluation. The price‑to‑earnings multiple is well below the industry average, and the price‑to‑book ratio remains modest, supporting a value‑oriented case. Combined with strong balance‑sheet metrics and a supportive regulatory environment, the outlook is positive across short, medium and long horizons, though investors should monitor loan‑growth trends and any shifts in macro‑economic conditions.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (SMA, MACD, RSI)
  • Strong loan growth driving earnings
  • Attractive dividend yield with sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant undervaluation versus DCF fair value
  • Stable balance sheet with ample cash and low leverage
  • Continued dividend income supporting total return

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Fundamental value gap offering upside potential
  • Consistent profitability and high return on equity
  • Resilient business model in a regulated banking sector

Key Metrics & Analysis

Financial Health

Revenue Growth-11.10%
Profit Margin49.34%
P/E Ratio10.9
ROE14.20%
ROA1.48%
P/B Ratio1.5
Op. Cash Flow£823.0M
Industry P/E16.6

Technical Analysis

TrendBullish
RSI62.6
Support£771.00
Resistance£900.00
MA 20£844.10
MA 50£820.44
MA 200£753.96
MACDBullish
VolumeIncreasing
Fear & Greed Index91.91

Valuation

Fair Value£1,950.54
GradeUndervalued
TypeValue
Dividend Yield9.34%

Risk Assessment

Beta0.59
Volatility27.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.